Skip to content
Home/Companies/Healthcare/Schülke

Schülke

Healthcare·Germany·Exited 2023·Held 3yr
Entry
2020
Hold
3yr
Exit
2023

Who owns Schülke?

Schülke is a German Healthcare company, now owned by ATHOS Consortium, which acquired it in 2023 from EQT.

Hand-verified · updated 2026-08-18

Open JSON · CC-BY
EQT
Investor
EQT
EQT VIII · 2018 · Buyout

Key facts

HQGermany
SectorHealthcare
StatusAcquired
Exit Type
Secondary
Buyer
ATHOS Consortium
Exit Year
2023

More from EQT VIII

Other portfolio companies in the same fund.

RIMES Technologies
Exited 2024
Data & AnalyticsUK· 2020
to Five Arrows (Rothschild & Co)
SHL Medical
Active
MedTechSwitzerland· 2020
Acumatica
Active
SaaSUS· 2019
Aldevron
Aldevron
Exited 2021
BiotechUS· 2019
to Danaher
AutoStore
Exited 2021
IndustrialsNorway· 2019
Dellner Couplers
Exited 2026
IndustrialsSweden· 2019
to Wabtec Corporation

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdvaCare
Active
Summit PartnersUS
Advance Health
Active
Summit PartnersUS

Questions

Who owns Schülke?

Schülke is now owned by ATHOS Consortium, which acquired it in 2023 from EQT.

When did ATHOS Consortium acquire Schülke?

ATHOS Consortium acquired Schülke in 2023, buying from EQT.

Who did Schülke sell to?

EQT sold Schülke to ATHOS Consortium in 2023 (Secondary).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue